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Abstract
Background: Maximizing comprehension is a major challenge for informed consent processes in low-literacy and
resource-limited settings. Application of rapid qualitative assessments to improve the informed consent process is
increasingly considered useful. This study assessed the effects of Rapid Ethical Assessment (REA) on comprehension,
retention and quality of the informed consent process.
Methods: A cluster randomized trial was conducted among participants of HPV sero-prevalence study in two
districts of Northern Ethiopia, in 2013. A total of 300 study participants, 150 in the intervention and 150 in the
control group, were included in the study. For the intervention group, the informed consent process was designed
with further revisions based on REA findings. Informed consent comprehension levels and quality of the consent
process were measured using the Modular Informed Consent Comprehension Assessment (MICCA) and Quality of
Informed Consent (QuIC) process assessment tools, respectively.
Result: Study recruitment rates were 88.7 % and 80.7 % (p = 0.05), while study retention rates were 85.7 % and
70.3 % (p < 0.005) for the intervention and control groups respectively. Overall, the mean informed consent
comprehension scores for the intervention and control groups were 73.1 % and 45.2 %, respectively, with a mean
difference in comprehension score of 27.9 % (95 % CI 24.0 % - 33.4 %; p < 0.001,). Mean scores for quality of
informed consent for the intervention and control groups were 89.1 % and 78.5 %, respectively, with a mean
difference of 10.5 % (95 % CI 6.8 -14.2 %; p < 0.001).
Conclusion: Levels of informed consent comprehension, quality of the consent process, study recruitment and
retention rates were significantly improved in the intervention group. We recommend REA as a potential modality
to improve informed consent comprehension and quality of informed consent process in low resource settings.
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Background
Informed consent comprehension is an important deter-
minant of study compliance and retention [1]. Quality in
the informed consent process include adequacy of the
information provided; understand-ability of the purpose,
benefits and risks of the research; distinction between
research and clinical care; voluntariness of participation;
recall of signing a consent document; and satisfaction
with the consent process as well as the levels of recall
and understanding by study participants [2]. Important
parameters in monitoring the quality of research imple-
mentation in addition to levels of study recruitment in-
clude levels recall and understanding of the informed
consent information by study participants [3–7]. To this
effect, informed consent documents may require to be
adapted to the local culture and the educational level of
the population, which have been shown to strengthen
research efforts, through improved recruitment and re-
tention of participants who better understand their roles
and responsibilities [8–10].
Rapid assessment techniques such as Rapid Ethical
Assessment (REA) have been documented to play an
important role in improving informed consent process
for medical research in developing countries by provid-
ing better understanding of research contexts [11–14].
REA is a brief (an average of 6 weeks long) qualitative
intervention designed to map the ethical terrain of the
research setting prior to a research team starts recruit-
ing participants with the purpose of connecting ethical
principles to contexts and realities on the ground. REA
attempts to discover, describe and respond to the ethical
issues specific to a particular research setting, and help
researchers to address the issues that genuinely matter
to proposed study participants and their community.
REA methodology involves interviews, focused discus-
sion and observation conducted among key stake-
holders to inform the design of the particular research
project. Its findings are utilised to inform and guide the
research consent process; ranging from the conception
and development of the consent form, to the way con-
sent is obtained. It has been documented that REA is
considered relevant and of utmost use for researchers
in low income settings [15]. However, the effects of
REA on study participants’ level of comprehension, re-
cruitment and retention and quality of informed con-
sent have not been documented.
The current study investigated effects of REA on in-
formed consent comprehension, study compliance and
quality of informed consent in a low-income setting.
We measured consent information comprehension level,
recruitment rate, retention rate and quality-of-informed
consent among the participants enrolled into another re-
search: “HPV-Subtype Prevalence Study” [16] in the Tigray
Regional State of Northern Ethiopia. The HPV study was
identified for the REA intervention due to potential ethical
issues anticipated in the study.
Methods
Study design
A cluster randomised controlled trial was conducted
among participants of an HPV Sero-prevalence study in
Northern Ethiopia, from July 8 to August 23, 2013. The
intervention for the trial was conducting REA and sub-
sequent revision of the informed consent's content and
processes based on the REA findings. The intervention
and control groups were compared for levels of compre-
hension, recruitment, retention (compliance) and perceived
qualities of the consent process two weeks after initial con-
sent. More description on the measurements is given in the
data collection procedures section below.
Source and study population
Pregnant women between 18-45 years attending ANC
follow-up in four selected health facilities and who were
targeted for the HPV sero-prevalence study were both
the source and study population for this comprehension
assessment. Those with communication challenge, severe
illness, gestational-age greater than 34 weeks, or those
who were not willing to return after two weeks for the
follow-up interview were excluded.
Sample size determination
Sample size was determined using the sample size formula
for double-population proportion -
n ¼ P1ð1− P1Þ þP2 1−P2ð Þ X f α; βð Þ
P2− P1ð Þ2
where ;
n : number of participants per group
p1 : expected levels of comprehension in the control
group
p2 : expected levels of comprehension in the interven-
tion group
α : degree of error
β : power of the study
Level of comprehension (P1) for the control group was
estimated based on an earlier study (hence P1 = 0.75) [3].
We assumed an improvement in the level of compre-
hension of 13 % (P2 = 0.88) for the intervention group
with 80 % power (β = 0.80), and 95 % confidence interval
(α = 0.05) (hence A(α, β) = 7.85). After adjusting for 10 %
non-response rate, the total sample size required was
300 participants with a 1:1 ratio between intervention
and control participants (i.e. 150 in each group).
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Sampling procedure
Two woredas (districts) targeted for the HPV sero-survey
were selected purposively based on comparability. The se-
lected woredas were randomly assigned using a lottery
method to either intervention or control. Health centres
within each of the woredas were shortlisted based on:
availability of Ante Natal Care (ANC) service provision, la-
boratory services, and appropriate professionals to collect
and handle specimen and flow of adequate number of
ANC clients. Two health centres from each woredas (i.e. a
total of four health centres), were randomly selected from
the shortlisted health centres (Fig. 1). Sample size was
proportionally allocated to the health facilities based on
reported flow of ANC clients in the previous one year
reported by the respective health bureau at the district
level.
Data collection procedures, instruments and variables
REA conducted at the beginning of recruitment identified
a number of ethical considerations. Based on these find-
ings revisions were suggested on (a) the consent form and
information sheet and (b) the consent process and proce-
dures (Table 1). Accordingly the IRB-approved consent
form (Additional file 1) was revised for the intervention
group (Additional file 2). The revisions made were: use of
additional local terminologies, concrete explanations of
study information with examples, and contextual clues
based on the REA findings. Consent information was pro-
vided by reading the information sheet to participants in
both groups. In the intervention group, this was accom-
panied by additional narratives which were attached to the
consent document based on the issues identified by REA.
Accordingly participants were asked whether they had any
questions after reading each section of the form, and once
more after the end of the entire reading. Consent in the
control group, was obtained by signing on the consent
form, but verbally in the intervention group with data col-
lectors signing as witnesses. Sentences and paragraphs in
the revised version of informed consent form were rela-
tively short, and the words chosen were more familiar and
local. The major characteristics of the two versions are
summarized in Table 1.
Level of comprehension of informed consent, and the
quality of the consent process were assessed two weeks
after consent had been taken. We used Modular Informed
Consent Comprehension Assessment (MICCA) and Brief
Investigator Questionnaire (BIQ) [17] to measure informed
consent comprehension of participants; and Quality of
Fig. 1 Flow-Chart showing the sampling procedures for the study. Illustrates the sampling procedures of the study and the steps followed in
the recruitment of study subject for the study. Recruitment of the study participants followed the REA (Rapid Ethical Assessment) which was
conducted at the very beginning. The study participant were in total 300, with 150 in the intervention and 150 in the control arms. They were
selected from two health centres in both instances and the number selected were proportional to the turn-out of patients in each
health institution
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Informed Consent (QuIC) [18] to assess quality of the
informed consent process. The MICCA and BIQ in-
struments for our assessment were developed by adopt-
ing the existing generic tools (Additional file 3). Both
tools have the flexibility to test comprehension specific
to a particular trial, yet can be utilized across a variety
of trials. MICCA measures comprehension by incorporat-
ing both generic and trial-specified approaches. Psycho-
metric evidence suggests that MICCA can be utilized in
various trial settings and can produce reliable and valid
scores [17].
Comprehension was assessed as a function of under-
standing and recall. Understanding refers to the con-
cepts explained in the consent process such as purpose,
benefits and risk. Recall refers to issues that needed to
be memorized such as date of appointment, and specific
procedures such as signature, copy of consent given or
not [19] (Table 2). A total of 25 questions were used to
assess informed consent comprehension of participants;
13 questions were used to assess levels of understanding
and 12 questions to asses levels of recall. Test items
consisted of both generic and trial specific questions
(Additional file 3). Of the 25 test items, 14 were generic
test items that appeared on each version of MICCA, 6
were trial-specific test items which were generated
based on responses to BIQ and the remaining 5 were
trial-specific test items in which the response options for
each of the test items are generated based on response to
BIQ. QuIC consisted of 13 subjective questions on the per-
ceived quality of the informed consent process (Additional
file 3). Each correct response was scored as 1, while each
incorrect response was scored 0. For multiple choices with
more than one correct response a score value of 1 was
given for each possible answer. All the correct answers for
understanding and recall were separately summed and cal-
culated out of hundred.
MICCA, BIQ and QuIC-based questionnaires for
the study were initially prepared in English (see
Additional file 3) and then translated to Tigrigna, the local
language. The Tigrigna version was translated back to Eng-
lish to check for consistency of meaning. Data collectors
who recruited participants and obtained initial consent
were nurses from the respective health centres, who had
been trained for the study. Comprehension assessment was
done by data collectors who had been trained on the use of
the assessment tools. Data collectors were supervised by
public health experts with postgraduate qualifications.
Data analysis
Data were pre-coded and entered into Epi-Info version
3.5.1. Data were cleaned and edited using simple fre-
quencies and cross tabulation and exported to SPSS Ver-
sion 16 for further analysis. Descriptive statistics were
generated for describing the study population in relation
to relevant socio-demographic variables. Regression ana-
lysis were done for comparative analysis and assessing
association between the major outcome variables and as-
sociated factors such as educational status, occupation
and previous participation in research. Risk ratios with
95 % confidence interval were used to determine levels
of significance. Multivariate logistic regression model was
used to control for confounders and adjust the measures
of association.
Table 1 Comparison of 'standard' and 'revised' versions of
information sheet, consent forms and procedures
Consent form information Revised version Standard version





Average words per sentence 12.4 16.3
Average words per paragraph 67.1 97.8
Average sentences per paragraph 5.6 7.6
Total words 604 587
Total number of paragraphs 9 6
Number of pages Two and a half Two
Average time taken (minutes) Mean = 10 ;
Median = 10
Mean = 9.6 ;
Median = 10
Used narrative explanations? Yes No






Type of consent seeking Verbal consent Signed document





Mean = 11.9 days
Median = 12 days
Table 2 Operational Definitions
Operational definitions
Comprehension Level: the level of participant understanding and
recall of the information they were given through the consent
document. Assessment is based on the Comprehension Test
administered two weeks into the study. Comprehension was
categorized into three levels [high :75 % or greater; medium:
between 50 % and 75 %; low: 50 % or less ] adapted from earlier
studies [3]. Its components included Recall and Understanding.
Recall: success in selecting or remembering the correct statement
Understanding: correctness of interpretations of statements presented
Study Recruitment rate: Recruitment rate is the proportion
(percentage) of participants who voluntarily decide to participate in
the study out of those who were approached to take part.
Study Compliance (or Retention) rate: Measures compliance to follow-up
and appointments as directed in the visit before. Compliance rate
refers to the proportion (percentage) of participant that attended
their appointment at the specified time divided by the number of
participants who were given an appointment and agreed to come.
Quality of informed consent process assessment: a measure of the
quality of consent process concerning information adequacy,
participant perception and satisfaction of the process, and the
situation of decision making during the recruitment process. Scoring
levels were the same as for comprehension.
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Results
REA findings
Rapid Ethical Assessment conducted at the beginning of
recruitment identified a number of ethical consider-
ations, based on which the consent form and process for
the intervention group were revised. Major REA findings
included low awareness of the concept of research
(therapeutic misconception), presence of indigenous de-
scriptions and terminologies for technical disease-related
terms; concerns about biological samples; major discom-
fort around signing a consent form; discomfort with
male enumerators; suspicions around the study selection
criteria; concerns with outsiders coming to the commu-
nity with incentives; and concerns over test results and
their implications. These findings dictated the need for
further elaboration on some of the components of the
research, for extended discussion on the issues identi-
fied, and for changes in the consenting mechanism.
Socio-demographic and economic characteristics of study
participants
A total of 300 pregnant women were approached for the
study, each half from control and intervention locations.
Of the 254 who consented (133 from intervention and
121 from control sites), 199 (114 from intervention and
85 from control site) also came to the follow-up visit
after two weeks and participated in the comprehension
assessment.
The mean age (±2 SD) of the participants who com-
plied with the follow-up appointment was 27.3 (+/-6.3)
years. Majority (83.4 %) were married; from the Tigre
ethnic group (99.5 %); Orthodox by religion (86.4 %);
able to read and write (70.8 %); and had a monthly fam-
ily income of >1000 Ethiopian Birr ETB) (61.8 %) which
is equivalent to 50 USD. For most participants (72.9 %),
it was the first time they had participated in any medical
research (Table 3).
Recruitment and retention rates
The overall study recruitment rate was 84.7 % with 88.7 %
in the intervention and 80.7 % in the control groups
(p = 0.05). The overall study retention rate was 78.3 %
with 85.7 % for the intervention and 70.3 % for the
control groups (p < 0.005). The loss-to-follow-up rates
after initial consent were 14.3 % and 29.8 % in the
intervention and control groups respectively.
Informed-consent comprehension scores
In the control group, majority (77.6 %) had low compre-
hension score (50 % or less). Only 4.7 % had high compre-
hension (75 % or greater) score. The remaining 17.6 % had
medium comprehension scores (between 50 % and 75 %).
In the intervention group, 43 % of participants had high
comprehension scores (75 % or greater), only 8.8 % had a
low comprehension score (50 % or less) and the remaining
48.2 % had a medium score (between 50 % and 75 %). Par-
ticipants in the intervention group were 4.6 times more
likely to have medium comprehension scores and were
14.5 times more likely to have high comprehension scores
than participants in the control group [Table 4]. The mean
comprehension scores of the two groups (intervention
and control) for all the 25 questions used in the compre-
hension test are presented in Table 5.
Participants in the intervention group obtained an
average score of 73.1 % in overall comprehension; 73.2 %
in the recall and 73.0 % in the understanding sections. Par-
ticipants in the control group obtained an average score of
45.2 % in the overall comprehension; 44.8 % in the recall
and 45.6 % in the understanding categories. There were
statistically significant mean differences in all the three
categories between the intervention and control groups
(p < 0.001). There was a significant net difference in the
mean score comprehension in almost all of the compo-
nents in the intervention group compared to the standard.
The highest mean difference (42.7 %) was observed in the
understanding of participant rights. There was no statisti-
cally significant mean score difference in disease-related
information between the intervention and control groups
[Table 6].
Further analysis was done for potential socio-demographic
factors associated with comprehension irrespective of
REA. Participants with higher educational level (secondary
and above) were found to be about 6.7 times more likely
(AOR= 6.68, 95 % CI 1.01 to 44.03) to obtain high scores
(> = 75 %) in the comprehension assessment than those
with no formal education. Participants who had ever par-
ticipated in any medical research were 2.8 times more
likely to score high (AOR = 2.77, 95 % CI 1.01 to 7.58)
than those who had never. Occupation and income was
also found significantly associated with high score of com-
prehension [Table 7].
Quality of informed consent
Overall, the mean informed consent quality assessment
score for the control group was 78.5 %, and that for the
intervention group was 89.1 % [Table 8]. More than
eighty percent (81.2 %) in the control and 99.1 % in the
intervention group were satisfied with the overall con-
sent process, while a statistically significant mean differ-
ence in the overall mean quality of informed consent
scores between the intervention and control groups. Sta-
tistically significant difference was detected in all but
three components of quality assessment [Table 8].
Discussion
The study demonstrated the possible impacts of REA on
study retention rate, levels of comprehension and quality
of the informed consent process among study participants
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in a low-income setting. REA conducted prior to recruit-
ment of participants revealed a number of relevant and
context-specific ethical issues concerning the HPV study
and its targeted study population. These findings helped
in adapting the study information sheet, consent form and
consent procedures to the local culture and educational
level of the population. The HPV study was selected for
the REA intervention due to expressed interest from the
investigators and expressed concerns in relation to the
sensitivity of the issues as the study deals with cancer of
the reproductive organ and sexually transmitted infection.
Such parameters which suggested that REA will be relevant
Table 3 Demographic and economic characteristics of respondents of WukiroKilte-Awulaelo and Hintal-wajiratworedas (districs),
Tigray region, Northern Ethiopia, July 2013
Variable (n = 199) Intervention f (%) (n = 114) Control f (%) (n = 85) Total f (%) (n = 199)
Age in years
18–24 34 (29.8 %) 38 (44.7 %) 72 (36.2)
25–31 45 (39.5 %) 30 (35.3 %) 75 (37.7)
32–38 30 (26.3 %) 14 (16.5 %) 44 (22.1)
39–45 5 (4.4 %) 3 (3.5 %) 8 (4)
Mean ( ± SD) 27.9 (±6.2) 26.4 (± 6.2 ) 27.3 (±6.3)
Marital status
Married 99 (86.8 %) 67 (78.8 %) 166 (83.4)
Single 5 (4.4 %) 8 (9.4 %) 13 (6.5)
Divorced 7 (6.1 %) 6 (7.1 %) 13 (6.5)
Widowed 3 (2.6 %) 4 (4.7 %) 7 (3.5)
Educational status
Not able to read and write 37 (32.5 %) 21 (24.7 %) 58 (29.1)
Able to read and write 11 (9.6 %) 6 (7.1 %) 17 (8.5)
Primary school 29 (25.4 %) 21 (24.7 %) 50 (25.1)
Secondary school 24 (21.1 %) 27 (31.8 %) 51 (25.6)
Diploma and above 13 (11.4 %) 10 (11.8 %) 23 (11.6)
Religion
Orthodox Christian 100 (87.7 %) 72 (84.7 %) 172 (86.4)
Muslim 13 (9.6 %) 10 (11.8 %) 23 (11.6)
Others (Catholic/Protestant) 1 (0.9 %) 3 (3.5 %) 4 (2.0)
Mother tongue
Tigrigna 114 (100 %) 83 (97.6 %) 197 (99)
Amharic 0 1 (1.2 %) 1 (0.5)
Others 0 1 (1.2) 1 (0.5)
Occupation
Housewife 24 (21.1 %) 47 (55.3 %) 71 (35.7)
Farmer 38 (33.3 %) 4 (4.7 %) 42 (21.1)
Merchant 28 (24.6 %) 6 (7.1 %) 34 (17.1)
Government employee 15 (13.2 %) 13 (15.3 %) 28 (14.1)
Private employee 4 (3.5 %) 10 (11.8 %) 14 (7.0)
Others (student, jobless) 5 (4.4 %) 5 (5.9 %) 10 (5.0)
Family monthly income
Less than 500ETBa 6 (5.3 %) 10 (11.8 %) 16 (8.0)
500-1000ETB 26 (22.8 %) 34 (40.0 %) 60 (30.2)
Greater than 1000ETB 82 (71.9 %) 41 (48.2 %) 123 (61.8)
Participated in medical research previously 21 (18.4 %) 15 (17.6 %) 36 (18.1)
a1 USD (US Dollar) ~ 19 ETB and GBP ~ 28.5 ETB
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Table 4 Level of informed consent comprehension in the intervention and control groups, WukiroKilte-Awulaelo and
Hintal-wajiratdistrics, Tigray region, Northern Ethiopia, July 2013
Comprehension Score Intervention Group f (%) (n = 114) Control Group f (%) (n = 85) RR (95 % CI) P value
Low [<=50 %] 10 (8.8) 66 (77.6) 1.00
Medium [50 %-75 %] 55 (48.2) 15 (17.6) 4.6 (2.9, 7.3) <0.0001
High [> = 75 %] 49 (43.0) 4 (4.7) 14.5 (5.6, 37.9) <0.0001
Table 5 Mean informed consent comprehension score (CS) of participants, Tigray region, Northern Ethiopia, July 2013








201 This health related study is a form of a researcha. [True] 44.7 30.6 14.1 (0.5 , 27.8 ) 0.043
202 Obligation to participate in this medical researcha. [False] 19.3 8.2 11.1 (1.2 , 21.0) 0.029
203 Told who is funding this researcha. [True] 46.5 34.1 12.4 (1.5 , 26.2 ) 0.080
204 Told the total number of people that participate in this researcha. [False] 57.9 44.7 13.2 (0.9, 27.3) 0.066
205 Except study team no one will be allowed to see my health informationa. [True] 65.8 81.2 15.4 (27.9, 2.9) 0.016
206 I will be told test results from this researchb. [False] 76.3 15.3 61.0 (49.7, 72.3) <0.0001
207 Treated for the infection tested by this researchb. [False] 63.2 11.8 51.4 (39.4, 63.4) <0.0001
208 I have been told contact person addressa. [True] 71.9 41.2 30.8 (17.5, 44.0) <0.0001
209 I will get a special care in my regular ANC follow upb. [False] 64.0 55.3 8.7 (5.1, 22.6) 0.215
210 My participation in the study can be stopped at any timea. [True] 81.6 20.0 61.6 (5.0, 72.8) <0.0001
211 I will be asked for costs related to my participation in this studya. [False] 80.7 50.6 30.1 (17.5, 42.7) <0.0001
212 I will be paid or got any incentive for participating in this studya. [False] 95.6 42.4 53.3 (43.1, 63.4) <0.0001
213 The sample taken in this study can be used for other purposea. [False] 87.7 49.4 38.3 (26.6, 50.0) <0.0001
301 Selection to participate in this studya. [A] 99.1 78.8 20.3 (12.5, 28.1) <0.0001
302 When to visit a doctor to avoid cervical cancerb. [B] 67.5 51.8 15.8 (2.1, 29.5) 0.024
303 Who analyze and discuss test resultsb. [A] 95.6 51.8 43.3 (33.6, 54.1) <0.0001
304 At what time can leave the study?a [A] 64.0 12.9 51.1 (39.0, 63.1) <0.0001
305 Agreed or signed to participate in this research meana. [C] 87.7 61.2 26.5 (15.1, 38.0) <0.0001
306 Can stop participation after you signed to participate?a [A] 73.3 21.2 52.5 (40.4, 64.6) <0.0001
307 Any difference made to regular ante natal care if not participate?a [B] 85.1 81.2 3.9 (6.6 , 14.5) 0.466
308 The main purpose(s) of the study?c
To know more about cancer disease in Ethiopia [A]
67.5 56.5 11.1 (2.6 , 24.7) 0.111
To introduce vaccine to benefit future generation of girls [B] 91.2 47.1 44.2 (33.1, 55.3) <0.0001
309 The main benefit(s) taking part in this research?c
Future generation of girls but not me will benefit. [C]
69.3 36.5 32.8 (19.5, 46.2) <0.0001
310 Procedure(s) asked to take part in?c
Giving a small amount blood for test [A]
96.5 65.9 30.6 (21.0, 40.3) <0.0001
Giving vaginal secretion for test [C] 91.2 56.5 34.8 (23.7, 45.8) <0.0001
311 Task(s) asked to complete?c
Attend appointment [A]
98.2 83.5 14.7 (7.3, 22.2) <0.0001
312 Side effect(s) that might occur during blood drawing for test?c
Pain or bruising on the vein [A]
57.0 41.2 15.8 (1.8, 29.9) 0.027
Bleeding at the site of the needle [B] 47.4 34.1 13.3 (0.6 , 27.1 ) 0.061
Over all C-Score 73.1 45.2 27.9 (23.96, 31.87) <0.0001
aGeneric test item- These test items appear on each version of MICCA
bTrial specific test item- These test items do not appear on every version of the MICCA. They are generated based on responses to BIQ
cTrial specific test items appear on each version of the MICCA. The response option for each of these test items are generated based on response to BIQ
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as the study was expected to generate ethical issues related
to the sensitivity of the subject, ambiguity of terms, and
decision-making dynamics of the community. The study
was conducted in a well-defined population group with
relative homogeneity in language, ethno-cultural and geo-
graphic parameters. The two study sites (intervention and
control) were similar to each other on major societal pa-
rameters. They were geographically adjacent to each other
and belonged to the same ethno-cultural cosmos including
the health system. The socio-demographic characteristics of
study participants in both locations revealed overall similar-
ity except few irregularities. We employed MICCA and
BIQ for measuring comprehension and QuIC for assessing
quality of informed consent. The tools were able to capture
both standard informed consent items as well as study-
specific test items [17]. Certain allowable practical ad-
justments were done on the tools and some of the
components, otherwise both tools have been validated
for use by researchers in different settings [17].
Recruitment rate and the recruitment index are con-
sidered important parameters in monitoring the quality
of research implementation [6, 7]. In this study higher
rates of both recruitment and retention were documented
for the intervention group. While we documented strong
statistical association between study retention rate and use
of REA-based revision on informed consent process, no
statistically significant difference was documented be-
tween the recruitment rates of the two groups. Previous
studies have tried to identify potential contributors to
recruitment rates of study participant such as 'opt-out'
approaches [20], early consideration of participants'
perspectives [21], addressing ethical issues such as the
therapeutic misconception [6], and establishing trust
between researchers and potential participants [22].
The recruitment rate, however, may have been affected
by other factors beyond the consent information as
the complexities of the challenges of recruitment are
also determined by the complexities of the respective
studies [7, 23, 24] and decisions being made prior to
recruitment based on information circulating in the
community [25].
Recruitment rate has been documented as an import-
ant determinant of subsequent retention [6, 24]. Other
factors affecting retention include mental state of the
person [26], availability of tracking and follow-up mech-
anisms [27], availability of mechanisms addressing com-
munity and context-specific issues and needs in special
communities [28]. However every study has its own pe-
culiar features and it may be difficult to generalise these
factors. The registered improvement in the study reten-
tion rate in our study may have resulted from improved
understanding of the consent information.
The current study documented significant differences
in the comprehension levels (understanding and recall)
between the intervention and control groups. REA-
based adjustments to the content and delivery of con-
sent information in the intervention group were linked
to the improved levels of understanding and recall in the
intervention group. These findings concur with studies
which have reported improved consent information
comprehension with appropriate interventions such as
provision of more explanation and socio-culturally tailored
Table 6 Comparison of percentage of participants giving correct responses to the main consent components in the intervention
and standard group, WukiroKilte-Awulaelo and Hintal-wajiratworedas(districts), Tigray region, Northern Ethiopia, July 2013
Consent component Mean % CS Intervention
N = 114)





Disease information [Q302] 67.54 51.77 15.8 (2.1, 29.5) 2.4
Information about the study[Q201, 203, 204, 208] 55.26 37.64 17.6 (9.46, 25.76) <0.001
Aim /purpose of the study[Q308A, 308B] 79.38 51.76 27.62 (19.53, 35.70) <0.001
Selection criteria [Q301] 99.12 78.82 20.30 (12.50, 28.10) <0.001
Procedure of sample collection [Q310A, 310C] 93.86 61.18 32.68 (25.21, 40.86) <0.001
Tasks to be performed by participants [Q311A] 98.25 83.53 14.70 (7.30, 22.20) <0.001
Risk of the study/ side effect of sample collection [Q312A, 312B] 52.19 37.65 14.55 (4.05, 25.04) 0.007
Benefit of the study [Q206, 207,209, 309C] 68.20 29.71 38.50 (29.38, 47.61) <0.001
Confidentiality [Q205, 213] 76.75 65.29 11.46 (2.21, 20.71) 0.015
Participant right [Q202, 210, 212, 304, 305, 306] 70.32 27.64 42.67 (36.35, 48.99) <0.001
Summary comprehension score
aUnderstanding 73.01 45.61 27.40 (22.60, 32.19) <0.001
bRecall 73.16 44.78 28.37 (23.34, 33.40) <0.001
Over all C- score 73.09 45.17 27.92 (23.97, 31.87) <0.001
aUnderstanding -score of Q201, 202, 205, 209, 210, 211, 212, 213, 301, 304, 305, 306, 307
bRecall- score of Q 203, 204, 206, 207, 208, 302, 303, 308A, 308B, 309C, 310A, 310C, 311A, 312A, 312B
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approach [29]. Provision of tailored terminologies and
additional narrative explanations on the pre-identified eth-
ical issues and allowing more time for discussion and
questions from the participants in the intervention group
might have been potential determinants. There was no sig-
nificant difference in comprehension levels related to dis-
ease information between the intervention and control
group. The reasons for non-significance could be the
sensitivity and novelty of the issues of cervical cancer
in the area.
In the study there was a significant difference in the
overall levels of perceived quality of the consent process
in the intervention compared to the control group. There
was a statistically significant difference in all but three of
the components of quality assessment; whether consent
form was read and explained carefully; whether consent
from was important source of information; and whether
consent form was important for consent decision. Possible
reasons for the improved perception of the quality of the
consent process in this study include the improvements
made in the consent information and the revised consent
procedures both of which were geared to the needs and
concerns of the potential participants, based on the REA.
There are several possible reasons for lack of statistically
significant improvements in three areas. Regarding read-
ability, the participants in the intervention groups mainly
Table 7 Variables associated with comprehension status among study participants in WukiroKilte-awulaelo and Hintalo-wajirat districts,
Tigray region, Northern Ethiopia, July 2013
Variables Comprehension score status (N = 199) AOR (95 % CI) P-value
High (> = 75 %) f(%) Low (<75 %) f(%)
Age in years
18–24 yrs. 23 (34.3 %) 49 (37.1 %) 1.09 (0.38, 3.10) 0.876
25–31 yrs. 26 (38.8 %) 49 (37.1 %) 1 ( Reference gp)
32–38 yrs. 16 (23.9 %) 28 (21.1 %) 1.7 (0.64, 4.55) 0.285
Marital status
Married 58 (86.6 %) 108 (81.8 %) 1 (Reference gp)
Single 3 (4.5 %) 10 (7.6 %) 1.05 (0.17, 6.58) 0.955
Divorced 4 (6.0 %) 9 (6.8 %) 0.59 (0.14, 2.53) 0.479
Religion
Ortho. Christian 54 (80.6 %) 118 (89.4 %) 1 (Reference gp)
Muslim 13 (19.4 %) 10 (7.6 %) 2.4 (0.80, 7.15) 0.089
Educational status
Not able to read and write 13 (19.4 %) 45 (34.1 %) 1 (Reference gp)
Able to read and write 6 (9.0 %) 11 (8.3 %) 2.20 (0.48, 10.15) 0.314
Within or completed primary school 15 (22.4 %) 35 (26.5 %) 2.23 (0.57, 8.72) 0.251
Within or completed secondary school 20 (29.9 %) 31 (23.5 %) 2.37 (0.52, 10.86) 0.266
Diploma and above 13 (19.4 %) 10 (7.6 %) 6.68 (1.01, 44.03) 0.048
Occupation
House wife 8 (11.9 %) 63 (47.7 %) 1 (Reference gp)
Private employee 4 (6.0 %) 10 (7.6 %) 3.39 (0.64, 17.92 0.151
Government employee 15 (22.4 %) 13 (9.8 %) 2.91 (0.62, 13.67) 0.177
Merchant 18 (26.9 %) 16 (12.1 %) 5.43 (1.78, 16.60) 0.003
Farmer 18 26.9 %) 24 (8.2 %) 9.05(2.79, 29.23) 0.000
Monthly family income
= < 500 ETB 3 (4.5 %) 13 (9.8 %) 0.67 (0.13, 3.35) 0.623
>500 & < 1000 ETB 9 (13.5 %) 51 (38.6 %) 0.38 (0.15, 0.96) 0.041
> = 1000 ETB 55 (82.1 %) 68 (51.5 %) 1 (Reference gp)
Previous participation
Yes 21 (18.4 %) 15 (17.6 %) 2.77 (1.01, 7.58) 0.047
No 85 (74.6 %) 60 (70.6 %) 1 (Reference gp)
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had the form read to them rather than reading it them-
selves. Another reason is that all three measures already
scored highly in the control group with little room for
improvements. Though not significant, there were im-
provements observed in the three categories and if a
larger sample had been used this might have been signifi-
cant. Quality of informed consent depends on factors such
as type of consent information provided, amount of infor-
mation, adequacy of comprehension, and the voluntariness
of decision making by the participants [5]. In the clinical
set up, participant-related factors such as age, IQ, level
of cognitive function and external locus of control were
associated with poor quality and information recall.
Written information provided immediately before ad-
mission was associated with better outcomes [30].
Various researchers have utilized different interven-
tions to improve the consent process and understanding,
such as use of local narratives [31], extended one-to-one
discussion [32–34], enhanced consent [33, 35], a revised
consent process [36], and a booklet of participants’ rights
[37]. Cultural and linguistic modifications to the informed
consent process were considered to significantly enhance
understanding by study participant in low income settings
[29]. On the other hand it has been shown that lexicosyn-
tactic readability improvement of the consent form [38],
multimedia enhanced consent [34], and use of a concise
version of the consent form [39] do not have effects on
comprehension. There are still ongoing evidence-based
debates as to which interventions are effective in enhan-
cing comprehension [40]. The intervention in this study
involved improvements changes in the consent procedures
based on REA findings.
One of the ethical dilemmas faced by the researchers
while revising the consent form is what level of change
on an IRB-approved form would be appropriate and
allowable once in the field, and what principles should
govern this. According to existing guidelines, any amend-
ments of an approved research project require further IRB
approval before implementation [41, 42]. The only excep-
tions to this are if the changes are immediately and ur-
gently required for the safety of the subjects. In this case,
the IRB must be informed immediately after establishing
the need for the changes -in most cases within five busi-
ness days [43]. The other possible exception to this rule is
if the study is a determined to be non-research by the IRB
and does not need further IRB follow-up [41]. We made
revisions to the consent form in the field on the following
basis; a) that the revision added to the approved consent
and did not reduce any major component (the consent
form content and structure approved by IRB were
maintained with improvements); b) that the comprehen-
sion assessment project and the possibility of revising the
consent form were already approved by IRB; c) that the
changes were important for the welfare of the subjects in
the study. Since getting approval from IRB for the
modification might take time, some provision for making
appropriate adjustment without tampering with the basic
components of consent may be necessary in future.
The Ottawa Statement provides a framework for ad-
dressing ethical issues around cluster randomised trials.
Table 8 Comparison of mean quality of informed consent process (QuIC) score from the participant’s perspective by intervention
group in WukiroKilte-Awulaelo and Hintal-wajiratdistricts, Tigray region, Northern Ethiopia, July 2013








There was sufficient time for consent discussion. [Agree] 93.9 82.4 11.5 (2.7, 20.3) 0.010
Agreed to participate in this study voluntarily and with full understanding. [Agree] 100 87.1 12.9 (6.7, 19.2) <0.001
Enrolment decision made mainly by me the respondent. [Agree] 99.1 92.9 6.2 (1.0, 11.3) 0.019
Discussed about the research with other patients or participants. [Agree] 91.2 17.6 8.9 (0.5, 18.2) 0.062
Consent form read or explained carefully. [Agree] 82.5 81.2 1.3 (-9.7 , 12.2) 0.818
Consent form was important source of information. [Agree] 92.1 88.2 3.9 (-4.5 , 12.2) 0.361
Consent form was easy to understand. [Agree] 97.4 90.6 6.8 (0.4, 13.2) 0.039
Consent form was important to the decision. [Agree] 95.6 95.3 0.3 (-5.6, 6.2) 0.915
Pressure from provider to sign/agree consent form. [Disagree] 95.6 76.5 19.1 (10.1, 28.2) <0.001
Sufficient opportunity to ask questions. [Agree] 95.6 67.1 28.6 (18.8, 38.3) <0.001
Questions answered thoroughly by the consent provider. [Agree] 99.1 74.1 25.0 (16.6, 33.4) <0.001
Satisfied with informed consent process. [Agree] 99.1 81.2 17.9 (10.4, 25.5) <0.001
Decision to participate was easy or very easy. [Agree] 99.1 87.1 12.1 (5.5, 18.6) <0.001
Mean score of Quality of informed consent 89.06 78.53 10.5 (6.8, 14.2) <0.001
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According to the statement on the Ethical Design and
Conduct of Cluster Randomized Trials, "When partici-
pants’ informed consent is required, but recruitment of
participants is not possible before randomization of clus-
ters, researchers must seek participants’ consent for trial
enrollment as soon as possible after cluster randomiza-
tion—that is, as soon as the potential participant has
been identified, but before the participant has undergone
any study interventions or data collection procedures"
[44, 45]. In the current study consent was obtained soon
after recruitment in to the planned study without further
additional approval of the REA based revisions on the
originally approved consent form, based on the premises
presented above.
The study has some potential limitations. Efforts were
made to ensure the uniformity of the intervention and
control sites, however there may have been undocumented
differences in the settings which may have confounded the
study outcomes. Both levels of comprehension and quality
of the informed consent process are based on participant
perceptions using questionnaire based interviews which
were not accompanied by independent observation
methods. This might reduce the objectivity and validity
of the responses. Reasons for loss to follow-up of those
who did not attend were not documented, and neither did
we document the basic socio-demographic characteristics
of non-attendees. The sample size determination was done
based on assumptions from other countries as there was
no local estimate available. In addition we assumed a 10 %
non-response rate while the non-response rate for the
study was about 15 %. The single cluster intervention also
might have reduced the study power.
Conclusions
Based on our findings, REA is associated with improved
understanding of study concepts, purposes and proce-
dures and participants’ perceptions of the informed con-
sent process. Investing in an intervention which enhances
researchers' understanding of the local context and tailor-
ing the consent information and process is associated with
improvement s in overall consent comprehension, study
recruitment rates and retention rates in low-income set-
tings. REA is also an appropriate intervention for further
use in similar settings and situations.
We would like to encourage researchers and research
ethics committees and policy makers to employ REA to
improve research consent comprehension, recruitment
and retention levels in certain low income settings. As
this is the first study exploring the effects of REA on
comprehension, additional studies in other settings with
more objective methods of measurement would provide
greater insight into the overall effects of REA on compre-
hension of consent. Such studies might even expand into
consent processes for medical interventions. Ethicists and
research policy makers are encouraged to explore the con-
sequences of utilizing REA in the light of IRB require-
ments and operating procedures. In future studies, if REA
is planned, it should be included in the research proposal,
so it and any subsequent consent form modification are
approved by the IRB.
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